Related Experiment Videos
Active bacterial core surveillance of the emerging infections program network
1Centers for Disease Control and Prevention, Mailstop C23, 1600 Clifton Rd., Atlanta, GA 30333, USA. aschuchat@cdc.gov
Emerging Infectious Diseases
|March 27, 2001
Summary
The Active Bacterial Core surveillance (ABCs) program monitors invasive bacterial diseases. In 1998, antibiotic resistance in Streptococcus pneumoniae was significant, but early-onset Group B Streptococcus disease declined.
Area of Science:
- Infectious Diseases
- Public Health Surveillance
- Microbiology
Background:
- The Active Bacterial Core surveillance (ABCs) program is a vital collaboration for monitoring invasive bacterial pathogens.
- It covers a population of 17 to 30 million, tracking diseases caused by Streptococcus pneumoniae, group A and B Streptococcus, Neisseria meningitidis, and Haemophilus influenzae.
Purpose of the Study:
- To describe the incidence rates of invasive diseases caused by key bacterial pathogens.
- To assess antibiotic resistance patterns in Streptococcus pneumoniae.
- To report trends in early-onset group B streptococcal disease.
Main Methods:
- Population-based active surveillance conducted by the Emerging Infections Program Network.
- Collection and study of bacterial isolates from invasive disease cases.
- Analysis of disease incidence and antimicrobial susceptibility data.
Main Results:
- In 1998, an estimated 97,000 invasive cases and 10,000 deaths were attributed to these pathogens in the US.
- 25% of invasive pneumococcal infections showed penicillin non-susceptibility; 13.3% were resistant to three antibiotic classes.
- Early-onset group B streptococcal disease decreased by 65% over the 6 years prior to 1998.
Conclusions:
- The ABCs program provides critical data on the burden and trends of invasive bacterial infections.
- Antimicrobial resistance in Streptococcus pneumoniae is a significant concern.
- Public health interventions have successfully reduced the incidence of early-onset group B streptococcal disease.